Structure (Tizanidine 4mg 1)
Tizanidine
Product Images NDC 45865-348
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 45865-348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig1 (Tizanidine 4mg 2)
Fig2 (Tizanidine 4mg 3)
The text describes the improvement of Ashworth score with the use of Zanidine over a period of 7 weeks with a mean dose of 28.6 mg. The improvement was measured at week 3 and the end of maintenance endpoint was observed at week 7 using the last observation carried forward method.*
Bottle Of 30 (Tizanidine 4mg 4)
This is a description of a medication called Tizanidine HCL in its 4 mg tablet form which is used as a generic alternative to Zanaflex. The product comes in a package of 30 tablets with a specific Lot number and is identified by its National Drug Code. The medication can cause dizziness and drowsiness; therefore, it is advised not to operate heavy machinery or drive. The intended dose is to take the tablet(s) two times per day.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
